Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...
Two years after Neil Armstrong walked on the Moon, US president Richard Nixon declared a new frontier in American scientific ...
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel ...
15h
Verywell Health on MSNThe 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
17h
Pharmaceutical Technology on MSNUnsafe and unregulated cell therapies being sold in EuropeThe EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
13h
Face2Face Africa on MSNMan makes history by becoming the first in New York to be cured of sickle cell anemia, doctors sayA Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...
In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and ...
18h
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
Synthetic ‘kill switch’ could fast track new immunotherapies, turning bacterial armies against cancer tumours, study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results